HK Inno.N EBITDA per Share

What does HK Inno.N do? HK inno.N Corp. generates revenue through its Prescription Drug segment, which manufactures and sells hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, and circulatory system products. The Health Beauty and Beverage (HB&B) segment contributes by producing and distributing hangover relieving products, health drinks, and food items. The Other segment earns income from trademark royalties and additional services. Products are sold domestically and internationally, targeting healthcare consumers and businesses seeking pharmaceutical and wellness solutions. The company's Prescription Drug segment focuses on specialized medical treatments, while HB&B targets health-conscious consumers with lifestyle products. Trademark royalties in the Other segment provide supplementary revenue from intellectual property licensing. Domestic sales form a significant portion of the business, with international markets expanding the company's reach. HK inno.N Corp. serves healthcare providers and end consumers through its Prescription Drug segment, with products like anticancer and high blood pressure drugs. HB&B products such as hangover relievers and health drinks cater to individual wellness needs. The Other segment’s trademark royalties support brand value, with sales spanning both local and global markets. HK Inno.N is one of the most popular companies on Eulerpool.